4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000201
CHIEF FINANCIAL OFFICER gave up 1,733 shares (to pay taxes)
- CHIEF FINANCIAL OFFICER acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WEAVER GREGORY L CHIEF FINANCIAL OFFICER | 2020-01-30 | Option exercise | +5,000 | 9,500 | D | ||
| WEAVER GREGORY L CHIEF FINANCIAL OFFICER | 2020-01-30 | Shares withheld for taxes | −1,733 | $3.91 | $6,776 | 7,767 | D |
| Derivatives | |||||||
| WEAVER GREGORY L CHIEF FINANCIAL OFFICER | 2020-01-30 | Option exercise · Restricted Stock Units | +5,000 | 15,000 | D | ||
Loading xslF345X03/form4-01312020_020141.xml…